Dr. Grimberg has been with Aposense for the past 14 years and has a strong background in innovation, research and new product development, driving product development as early as from the idea stage. Dr. Grimberg is responsible for leading Aposense’s therapeutic R&D projects through all development stages. Prior to her current position Dr. Grimberg served as Project Manager at Aposense. Dr. Grimberg obtained an M.Sc in Biochemistry from the Ben-Gurion University and a Ph.D in Physiology & Pharmacology from the Tel Aviv University. Dr. Grimberg has published several articles in leading journals and was awarded with numerous patents.
Hagit Grimberg, Ph.D